Literature DB >> 1515827

Early treatment with parenteral penicillin in meningococcal disease.

K Cartwright1, S Reilly, D White, J Stuart.   

Abstract

OBJECTIVE: To measure the effect of parenteral antibiotics given before admission to hospital on mortality and on bacteriological investigations in meningococcal disease.
DESIGN: Retrospective review of hospital notes and laboratory and public health medicine department records.
SETTING: Three health districts in south west England.
SUBJECTS: Patients with meningococcal disease in Gloucester district presenting between 1 January 1982 and 31 December 1991 (n = 190); patients with meningococcal disease in Plymouth (n = 118) and Bath (n = 73) districts presenting between 1 January 1988 and 31 December 1991 (total = 381). MAIN OUTCOME MEASURE: Number of deaths from meningococcal disease.
RESULTS: Parenteral antibiotic given by general practitioners was associated with a substantial reduction in mortality (from 9% to 5%; relative risk 0.6, 95% confidence interval 0.2 to 1.5); patients with a rash were more likely to be given parenteral antibiotics, and mortality was further reduced (from 12% to 5%; 0.5, 0.2 to 1.4). In a district where such treatment was regularly encouraged its use increased from 5% to 40% of cases over 10 years (p = 0.00001). Treatment with parenteral antibiotics before admission made isolation of meningococci from blood and cerebrospinal fluid less likely but did not affect nasopharyngeal cultures.
CONCLUSIONS: General practitioners should carry benzylpenicillin in their emergency bags at all times and should administer it promptly, preferably intravenously, whenever meningococcal disease is suspected, unless the patient has had an anaphylactic reaction to penicillin. Specimens for culture should include a nasopharyngeal swab.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515827      PMCID: PMC1883180          DOI: 10.1136/bmj.305.6846.143

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  32 in total

1.  Acute bacterial maningitis in childhood: aspects of prehospital care in 687 cases.

Authors:  M J Goldacre
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  Prognostic Factors in meningococcal disease.

Authors:  P M Niklasson; P Lundbergh; T Strandell
Journal:  Scand J Infect Dis       Date:  1971

3.  Completeness of statutory notification for acute bacterial meningitis.

Authors:  M J Goldacre; D L Miller
Journal:  Br Med J       Date:  1976-08-28

4.  Meningococcal infections during infancy: confidential inquiries into 10 deaths.

Authors:  J R Oakley; A N Stanton
Journal:  Br Med J       Date:  1979-08-25

5.  Meningococcal infections in Scotland 1972-82.

Authors:  R J Fallon; W M Brown; W Lore
Journal:  J Hyg (Lond)       Date:  1984-10

6.  The early phase of meningococcal disease.

Authors:  T Tønjum; F Nilsson; J N Bruun; B Haneberg
Journal:  NIPH Ann       Date:  1983-12

7.  Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence.

Authors:  E A Edwards; L F Devine; G H Sengbusch; H W Ward
Journal:  Scand J Infect Dis       Date:  1977

8.  Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital.

Authors:  J R Strang; E J Pugh
Journal:  BMJ       Date:  1992-07-18

9.  The endotoxin-liberating effect of antibiotics on meningococci in vitro.

Authors:  B M Andersen; O Solberg
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-08

10.  Deaths from meningococcal infection in England and Wales in 1978.

Authors:  J Slack
Journal:  J R Coll Physicians Lond       Date:  1982-01
View more
  64 in total

1.  Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

Authors:  C Trujillo
Journal:  BMJ       Date:  2000-01-22

2.  Meningococcal disease and healthcare workers.

Authors:  A J Pollard; N Begg
Journal:  BMJ       Date:  1999-10-30

3.  Nonculture prediction of Neisseria meningitidis susceptibility to penicillin.

Authors:  A Antignac; J M Alonso; M K Taha
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Improved rate of isolation of Neisseria meningitidis by direct plating of pharyngeal swabs.

Authors:  R Cunningham; R Matthews; G Lewendon; S Harrison; J M Stuart
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Laboratory confirmation of meningococcal disease in Scotland, 1993-9.

Authors:  S C Clarke; J Reid; L Thom; B C Denham; G F S Edwards
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

6.  Epidemiology and prognostic factors in meningococcal disease in a small island population: Malta 1994-1998.

Authors:  T Piscopo; C Mallia-Azzopordi; V Grech; M Muscat; S Attard-Montalto; C Mallia
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

7.  Improving promptness of antibiotic treatment in meningococcal disease.

Authors:  F A Riordan
Journal:  Emerg Med J       Date:  2001-05       Impact factor: 2.740

8.  5' exonuclease assay for detection of serogroup Y Neisseria meningitidis.

Authors:  William S Probert; Susan L Bystrom; Shideh Khashe; Kimmi N Schrader; Jane D Wong
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 9.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

10.  Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Authors:  M K Taha
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.